These findings will not only advance our understanding of the mechanism underlying cell cycle regulation and tumorigenicity, but also establish MNX1 as a key regulator of bladder cancer progression and a valuable prognostic marker, and may also facilitate the development of new therapeutic strategies against bladder cancer. Here, MNX1 is linked to urinary bladder cancer.